SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission by Kim, Moshe S. et al.
JCB: Article
The Rockefeller University Press    $30.00
J. Cell Biol. Vol. 195 No. 5  815–826
www.jcb.org/cgi/doi/10.1083/jcb.201106131 JCB 815
Correspondence to William S. Trimble: wtrimble@sickkids.ca
Abbreviations used in this paper: CMV, cytomegalovirus; MBP, maltose-bind-
ing protein; MCS, multiple cloning site; NTA, nitrilotriacetic acid; shRNA, small 
hairpin RNA.
Introduction
Septins are a family of filament-forming GTP-binding proteins 
that have been implicated in diverse cellular processes (Hall, 
2008). Much work has focused on the role of septins in cell divi-
sion in which they mediate the physical division of the cytoplasm. 
This process, called cytokinesis, is necessary to ensure that each 
daughter cell inherits the correct complement of chromosomes. 
Because defects in cytokinesis have been linked to cancer 
(Fujiwara et al., 2005; Ganem et al., 2007; Sagona and Stenmark, 
2010), it is not surprising that altered expression of individual 
septins is also associated with various human malignancies. For 
example, changes in the expression of SEPT9 or amplification of 
the SEPT9 locus has been linked to sporadic ovarian and breast 
cancers (Burrows et al., 2003; Montagna et al., 2003; Scott et al., 
2006; Gonzalez et al., 2007). However, the precise role of septins 
in cytokinesis and malignant transformation remains unknown.
Septins associate with each other to form complexes, 
which in turn assemble in an end to end fashion to form long   
filaments. The best-characterized septin complex is that of the 
budding yeast Saccharomyces cerevisiae. This complex com-
prises near stoichiometric ratios of the four major yeast septins, 
Cdc3, Cdc10, Cdc11, and Cdc12, and electron microscopy 
revealed that these subunits had a rod-shaped appearance (Frazier 
et al., 1998). Moreover, by tagging individual septins, Bertin   
et al. (2008) demonstrated that these rods were nonpolar octamers 
composed of two tetramers with mirror symmetry and ordered 
Cdc11–Cdc12–Cdc3–Cdc10–Cdc10–Cdc3–Cdc12–Cdc11.
In  mammals,  14  genes  encode  septin  proteins  (called 
SEPT1–SEPT14), and most of these genes undergo alterna-
tive splicing to produce multiple isoforms (Russell, 2008). In 
particular, SEPT9 has been shown to undergo alternative tran-
script initiation and splicing at the N and C termini, giving 
rise to 18 different transcripts that would encode 15 different 
isoforms (McIlhatton et al., 2001). The longer N-terminal vari-
ants (SEPT9_i1–3) have small unique sequences spliced to a 
common exon (exon 3), whereas SEPT9_i4 splices into exon 3, 
deleting most of it, and SEPT9_i5 lacks all of exon 3.
Only a subset of the 14 septin genes and isoforms appears 
to be expressed in a given cell, suggesting that mammalian 
septin complexes may differ in composition in different cell and 
tissue types. Based on sequence similarity, the 14 septin genes 
fall into the following four subgroups (Kinoshita, 2003; Peterson 
et al., 2007): the SEPT2 subgroup (septins 1, 2, 4, and 5), the 
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in an octameric septin complex. A mutant SEPT9, which 
cannot self-associate, disrupted septin filament formation 
and resulted in late abscission defects during cytokinesis 
but did not affect septin-dependent steps earlier in mitosis. 
These data suggest that mammalian SEPT9 holds a termi-
nal position in the septin octamers, mediating abscission-
specific polymerization during cytokinesis.
SEPT9 occupies the terminal positions in septin 
octamers and mediates polymerization-dependent 
functions in abscission
Moshe S. Kim,
1,2 Carol D. Froese,
1,2 Mathew P. Estey,
1,2 and William S. Trimble
1,2
1Program in Cell Biology, Hospital for Sick Children, and 
2Department of Biochemistry, University of Toronto, Toronto, Ontario M5G 1X8, Canada
© 2011 Kim et al.  This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publication date (see 
http://www.rupress.org/terms). After six months it is available under a Creative Commons 
License  (Attribution–Noncommercial–Share  Alike  3.0  Unported  license,  as  described  at 
http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 195 • NUMBER 5 • 2011   816
To definitively resolve the position of SEPT9 within the 
octamer, we generated mutations that would distinguish be-
tween SEPT9 occupying an innermost or outermost position. 
Using tandem affinity pull-downs and mutagenesis of indi-
vidual septin interaction surfaces, we confirm the order of 
septins predicted by the crystal structure and demonstrate 
that SEPT9 occupies the ends of an octameric mammalian 
septin  complex  such  that  the  order  is  9–7–6–2–2–6–7–9. 
Moreover,  by  introducing  mutations  that  prevent  SEPT9 
self-association at the NC interaction surface, we show that 
septin filament disruption causes defects in the late stages of 
cell  division  before  abscission,  similar  to  those  observed 
upon SEPT9 depletion.
Results
SEPT9 associates with other septins on 
fibers and rings
Crystallography of a complex of mammalian SEPT2, SEPT6, 
and  SEPT7  expressed  in  bacterial  cells  revealed  a  nonpolar 
hexameric complex ordered SEPT7–SEPT6–SEPT2–SEPT2–
SEPT6–SEPT7 (Sirajuddin et al., 2007). However, most cells 
characterized to date express additional septins, and we have 
demonstrated that HeLa cells express septins 2, 6, 7, 9, and 11 
(Estey et al., 2010). Moreover, when SEPT9 was immuno-
precipitated from HeLa cells, other septins coimmunoprecipitated, 
including SEPT2, SEPT6, SEPT7, and SEPT11 (Surka et al., 
2002; Estey et al., 2010). We first asked whether SEPT9 associ-
ated with other septins in higher-ordered filamentous structures. 
Septins are known to adopt higher-order structures that resem-
ble filaments and rings in vitro and in vivo. In fibroblast cells 
that contain central actin stress fibers, septins appear filamen-
tous and have been shown to colocalize with subnuclear actin 
stress fibers (Kinoshita et al., 1997, 2002; Frazier et al., 1998; 
Xie et al., 1999; Nagata et al., 2004; Kremer et al., 2007). As 
shown in Fig. 1 A, in HeLa cells, SEPT2 and SEPT7 appear fila-
mentous, colocalizing with actin stress fibers. Immunostaining 
with SEPT9 antibodies revealed strong colocalization with both 
SEPT2 and SEPT7 in these fibers.
Latrunculin B or cytochalasin D disrupts F-actin and un-
couples septins from actin, causing them to form short curvi-
linear structures that curl and ultimately form rings (Xie et al., 
1999; Kinoshita et al., 2002). In vitro, when salt concentra-
tions are lowered, septin complexes have been shown to form 
filaments that bundle laterally and self-assemble into rings 
(Kinoshita et al., 2002). Upon disruption of actin with cyto-
chalasin D, SEPT2 and SEPT7 filaments reorganize into actin- 
independent rings with typical diameters of 0.45 µm (Fig. 1 B). 
SEPT9 also strongly colocalized with both SEPT2 and SEPT7 
in these rings (Fig. 1 B). Thus, SEPT9, a member of the fourth 
septin subgroup, is associated with other septins on actin-
templated septin fibers and actin-independent septin rings.
SEPT9 depletion disrupts septin fibers and 
reduces ring size
Next,  we  asked  whether  depleting  individual  septins  could 
interfere with septin higher-ordered structures, such as fibers 
SEPT3 subgroup (septins 3, 9, and 12), the SEPT6 subgroup 
(septins 6, 8, 10, 11, and 14), and the SEPT7 subgroup (septins 
7 and 13). Although they do not have a simple orthologous rela-
tionship to the yeast septins (Pan et al., 2007), the four mamma-
lian septin subgroups do have structural similarity to the four 
yeast  septins  (Versele  and Thorner,  2005).  For  example,  all 
yeast septins except Cdc10 have coiled-coil domains near their 
C termini. The same is true for three of the four mammalian 
septin subgroups, with SEPT3 subgroup members lacking a 
coiled  coil.  It  has  therefore  been  proposed  that  mammalian 
septins may assemble into complexes in a manner analogous to 
that observed in yeast. Recently, Sellin et al. (2011) demon-
strated that mammalian septin complexes immunopurified from 
multiple cell types consist of a member of each of the four 
septin groups. Thus, mammalian septins likely assemble into 
complexes that might be analogous to budding yeast.
To date, the best description of a mammalian septin 
complex comes from crystallography analyses in which three 
mammalian septins coexpressed in bacteria were purified and 
crystallized (Sirajuddin et al., 2007). They were found to form 
an apolar hexameric complex that was ordered SEPT7–SEPT6–
SEPT2–SEPT2–SEPT6–SEPT7. The crystal structure not only 
revealed the order of these three septins but also showed that 
the septin subunits interacted with each other at one of two inter-
action surfaces in an alternating manner. The first interaction 
surface involved the nucleotide-binding domains (G interface), 
whereas the other surface comprised the N- and C-terminal   
domains (NC interface). However, because the crystal structure 
was derived from a specific combination of recombinant septins, 
it remains unclear whether this organization holds true for   
native mammalian septin complexes. More importantly, bio-
chemical and immunofluorescence studies on septin complexes 
from HeLa cells clearly show that SEPT9 is part of the septin 
complex (Surka et al., 2002; Estey et al., 2010), yet this septin was 
not included in the crystallography studies. How SEPT9 fits into 
the canonical 7–6–2–2–6–7 complex and whether septins might 
substitute for each other within the same subgroup were recently 
addressed by Sellin et al. (2011). They showed that native septin 
complexes immunoisolated from multiple mammalian cell types 
expressing  different  septin  combinations  were  all  capable  of 
disassembling into protomeric octamers. This implied that cell 
lines expressing multiple members of one subgroup were likely 
generating many different types of octamers, with each member 
of a subgroup capable of substituting for another member of that 
subgroup. Furthermore, SEPT9 depletion resulted in a shift to a 
hexameric state, suggesting that SEPT9 might occupy a terminal 
position in the native octameric complex. An alternative, but not 
implausible, interpretation is that SEPT9 may occupy an internal 
position in the native octameric complex and that, after SEPT9 
depletion, the trimeric 2–6–7 halves come together because of 
the plasticity of the septin complex. In support of this, the yeast 
septin  complex  displays  remarkable  plasticity.  For  instance, 
removal of the innermost yeast septin (Cdc10) results in a re-
ordered hexameric complex with trimeric Cdc3–Cdc12–Cdc11 
halves being joined together (McMurray et al., 2011). In addi-
tion, the innermost yeast septin (Cdc10) is structurally related to 
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nearby untransfected control cells (Fig. 2 B). A closer examina-
tion of SEPT2 fiber structures in these SEPT9-depleted cells 
revealed short rudimentary filaments that were more clearly   
resolved when deconvolved (Fig. 2 B, bottom). Induction of septin 
rings using cytochalasin D resulted in smaller septin rings   
in SEPT9-depleted cells when compared with surrounding 
and rings. In HeLa cells, SEPT9 was depleted by targeted gene 
knockdown using a small hairpin RNA (shRNA) plasmid with 
a GFP reporter (Fig. 2 A). The remaining septin structures were 
assessed by immunostaining with SEPT2 antibodies in the pres-
ence or absence of cytochalasin D (Fig. 2, B and C). Cells lack-
ing SEPT9 showed disrupted septin fibers when compared with 
Figure 1.  Colocalization of SEPT9 with septin fibers and rings. (A) Actin-templated septin fibers in interphase HeLa cells. (top) Immunofluorescent staining 
of SEPT2 fibers (red) and colocalization with phalloidin-stained actin stress fibers (green). Boxed areas of septin fibers are magnified on the right. (middle) 
Colocalization of SEPT9 with SEPT2 fibers. (bottom) Colocalization of SEPT9 with SEPT7 fibers. (B) Actin-independent septin self-assembly into rings upon 
treatment with cytochalasin D. (top) Immunofluorescent staining of SEPT2 rings (red) and colocalization with SEPT9. (bottom) SEPT9 colocalizes with SEPT7 
rings upon cytochalasin D treatment. Bars: (main images) 5 µm; (zoom) 1 µm.JCB • VOLUME 195 • NUMBER 5 • 2011   818
adopt an alternate higher-ordered configuration that supported 
suboptimal filaments and smaller rings.
In cells lacking SEPT2, there also appeared to be rudi-
mentary filaments (Fig. 2 E), but these did not assemble into 
untransfected control cells (Fig. 2 C). Quantitative analysis of 
these septin rings revealed a 23% reduction in ring diameter 
in  SEPT9-depleted  cells  when  compared  with  control  cells   
(Fig. 2 D and Fig. S1). Thus, the remaining septins were able to 
Figure 2.  SEPT9 knockdown disrupts septin fibers and rings. (A) Transfection of control (CTRL) or SEPT9 shRNA constructs in HeLa cells immunoblotted 
with SEPT9 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies. Molecular masses are given in kilodaltons. (B) Disruption of septin fibers 
with SEPT9 knockdown (KD). HeLa cells transfected with SEPT9 shRNA carrying a GFP reporter. GFP-positive cells are pseudocolored pink in the inset.   
(top) Immunofluorescent staining of SEPT2 (red) and SEPT9 (green) using rabbit polyclonal and mouse monoclonal antibodies, respectively. The merged 
image shows reduction of SEPT9 staining in knockdown cells. (bottom) Boxed areas are magnifications of nontransfected and transfected SEPT9 knockdown 
cells. SEPT9 knockdown cells have disrupted SEPT2 fibers (raw and deconvolved [Deconv] images). (C) Disruption in higher-order structure of septin rings 
with SEPT9 knockdown upon cytochalasin D treatment. (top) Immunofluorescent staining of SEPT2 (red) and SEPT9 (green) using rabbit polyclonal and 
mouse monoclonal antibodies, respectively. SEPT9 knockdown cells are GFP positive (pink, inset) and show reduced SEPT9 staining relative to SEPT2. 
(bottom) Boxed areas are magnifications of nontransfected and transfected SEPT9 knockdown cells. SEPT9 knockdown cells have smaller SEPT2 rings 
compared with untransfected control (raw and deconvolved images). (D) Quantitation of SEPT2 rings in control (n = 87) and SEPT9 knockdown (n = 230) 
rings. Mean diameters of 0.35 and 0.45 µm were observed for SEPT9 knockdown and control cells, respectively (horizontal lines). (E and F) The effect of 
SEPT2 knockdown on SEPT9 fibers (E) and rings (F). Knockdown cells are indicated with asterisks. Bars: (main images) 5 µm; (zoom) 1 µm.819 Mammalian septin filaments mediate abscission • Kim et al.
To determine the order of the septins within the septin 
complex, we first developed mutations that blocked interaction 
at the SEPT6–SEPT7 interface. The interaction of SEPT6 and 
SEPT7 occurs at an NC interface where their predicted coiled 
coils are closely apposed and project orthogonally to the hex-
amer axis. The coiled coils of SEPT6 and SEPT7 interact with 
each other directly (Low and Macara, 2006; Shinoda et al., 
2010), and in yeast, septin coiled coils are necessary and suffi-
cient for septin interaction (Versele et al., 2004), so we deleted 
the coiled-coil domain of SEPT6. As shown in Fig. 3 C, MBP-
SEPT2 and His6-SEPT7 were coexpressed alone or with either 
full-length  SEPT6  or  SEPT6  lacking  its  coiled-coil  domain 
(SEPT6C). Expression of the individual septins was confirmed 
in the input lanes by blotting for FLAG (Fig. 3 C, lanes 1–3), 
but tandem purification of SEPT2 and SEPT7 only occurred 
when full-length SEPT6 was present (Fig. 3 C, lane 5). Al-
though not detected by tandem affinity purification (Fig. 3 C, 
lane 6), single affinity purification revealed that SEPT6C puri-
fied with MBP-SEPT2 on the amylose column, whereas His6-
SEPT7 was found alone on the Ni–nitrilotriacetic acid (NTA) 
agarose column (not depicted). This indicates that the coiled 
coil of SEPT6 is necessary for its interaction with SEPT7 and 
that SEPT6 is between SEPT2 and SEPT7, consistent with the 
organization predicted by the crystal structure.
When SEPT9 was cotransfected with the other septins, a 
four-septin complex was isolated under the same purification 
conditions. Similar to the SEPT2–6–7 complex, this complex 
required the presence of SEPT6 (Fig. 3 E, lane 5). Disrupting 
the SEPT6–7 interaction using the SEPT6C mutant confirmed 
the stable association of SEPT2 with SEPT6 and SEPT7 with 
SEPT9 (Fig. 3 E, lanes 9 and 10). This suggests that SEPT9 
occupies the terminal position in the septin unit complex, ad-
jacent to SEPT7 (Fig. 3 D). Because the NC and G interfaces 
alternate in the septin complex, SEPT9 and SEPT7 would inter-
act with SEPT7 at their G interfaces. To test this possibility, 
we created a mutation in the G interface of SEPT7 (W249A; 
Sirajuddin et al., 2007; McMurray et al., 2011). We replaced 
the  strong  cytomegalovirus  (CMV)  promoter  with  a  cloned 
fragment of the SEPT2 promoter to drive much lower expres-
sion of either wild-type GFP-FLAG-His6-SEPT7 or the SEPT7 
G mutant. These constructs were then expressed in HeLa cells 
and pulled down using Ni-NTA agarose beads. Both wild-type 
and G mutant SEPT7 complexes pulled down similar amounts 
of endogenous SEPT2 and SEPT6 (Fig. 3 F, lanes 5 and 6). How-
ever, endogenous SEPT9 isoforms were pulled down much less 
efficiently in SEPT7 G mutant complexes compared with wild 
type (Fig. 3, F [lane 6] and G). Residual amounts of SEPT9 
isoforms in the SEPT7 G mutant complex could be caused by   
binding at the other tetrameric arm of the complex, where endog-
enous SEPT7 may have incorporated.
This indicates that SEPT9 is located at the ultimate po-
sition of the septin complex, which appears to be an octamer. 
Therefore, our data suggest that mammalian septin complexes 
have an organizational arrangement similar to yeast, with SEPT9 
being the outermost septin, so that the organization is SEPT9–
SEPT7–SEPT6–SEPT2–SEPT2–SEPT6–SEPT7–SEPT9. Be-
cause mammalian SEPT9 and yeast Cdc10 are both in the same 
septin  rings  (Fig.  2  F).  The  plasticity  observed  in  septin 
higher-order structures appears to be dependent on the partic-
ular septin being removed from the complex. The effects of 
depletion of SEPT2 and SEPT9 on septin fiber and ring for-
mation may correlate with the positional arrangement of the 
septins in the unit complex. To further investigate the organi-
zational arrangement of mammalian septins in the unit com-
plex, we sought to determine where SEPT9 might be in the 
septin complex.
SEPT9 is a terminal septin subunit in the 
SEPT2–6–7 complex
The  mammalian  septin  hexamer  (SEPT7–SEPT6–SEPT2–
SEPT2–SEPT6–SEPT7) has been shown to polymerize in vitro 
and is sufficient to form septin bundles and rings (Kinoshita   
et al., 2002; Sirajuddin et al., 2007). However, it is possible that 
these hexamers might represent a suboptimal configuration for 
mammalian septin assembly and that a septin from the SEPT3 
group  might  be  needed  for  efficient  septin  polymerization 
and function. Native mammalian septin complexes comprise 
a septin from each of the four septin groups and assemble as 
octamers (Sellin et al., 2011). In addition, we observe distinct 
effects on septin polymerization when SEPT9 is added in con-
junction  with  SEPT2–6–7  overexpression.  Under  conditions 
of septin overexpression, when HeLa cells are cotransfected 
with SEPT2, SEPT6, and SEPT7, septin filaments are short and 
stubby. However, when SEPT9 isoforms are cotransfected with 
the other three septins, septin filaments are much longer and 
thicker (Fig. S2).
In  yeast,  removal  of  the  innermost  (Cdc10)  or  outer-
most (Cdc11) septin in the octamer gives rise to suboptimal 
filaments (McMurray et al., 2011). These might be similar to 
the suboptimal filaments that result from depletion of SEPT9 
in  mammalian  cells. Thus,  SEPT9  might  be  found  at  the   
innermost or outermost position in the octameric complex. To 
confirm that the order of the septins matched that predicted by 
the crystal structure and to determine where SEPT9 fits into 
this complex, we first developed a small-scale method for pu-
rifying equal amounts of SEPT2, SEPT6, and SEPT7. We used a 
similar tandem affinity purification scheme and retained simi-
lar affinity tags on the septins as described previously (Sirajuddin   
et al., 2007). HeLa cells were triply transfected with three septin 
plasmids and purified by tandem affinity purification using poly-
histidine (His6) and maltose-binding protein (MBP) as affinity 
tags. One affinity tag, MBP, was fused to SEPT2, and the other 
affinity tag, His6, was fused to SEPT7, whereas SEPT6 did not 
contain an affinity tag. All plasmids carried a FLAG epitope 
to monitor septin complex purification. After tandem affinity 
purification, the resultant septin complexes contained equimo-
lar amounts of SEPT2, SEPT6, and SEPT7 when immunoblot-
ted for FLAG (Fig. 3 A, lane 4). The presence of each septin 
was further confirmed by immunoblotting with each individual 
septin antibody (Fig. 3 A, lanes 1–3). In addition, no endoge-
nous septins copurified with the complex (Fig. S3), and SEPT6 
was required for septin complex assembly, consistent with the   
possibility  that  it  connects  MBP-SEPT2  and  His6-SEPT7   
(Fig. 3 C, lane 4).JCB • VOLUME 195 • NUMBER 5 • 2011   820
subgroup, which lack coiled coils (Fig. 3 H), it is interesting to 
note that Cdc10 is located at the middle of the complex, whereas 
SEPT9 is found at the ends (Fig. 3 I). Any septin that occupies 
a terminal position in the octameric unit complex is predicted to 
mediate end-on-end polymerization. To inhibit polymerization, 
a mutation in the terminal septin that preserves the octameric 
unit but prevents addition at these ends was created. This mu-
tation was recently characterized in budding yeast (McMurray   
et al., 2011).
SEPT9N prevents self-association  
and interferes with septin fiber and  
ring structures
In budding yeast, septin filaments have recently been shown to be 
required for cytokinesis (McMurray et al., 2011). In that study, 
a Cdc11 deletion mutant in the 0 helix prevented homotypic 
Cdc11–Cdc11 interactions at the NC interface. This resulted in 
septin octamers that were not capable of polymerizing into fila-
ments. To address whether we could disrupt septin higher-order 
structures by preventing interaction at the SEPT9–SEPT9 in-
terface, we generated a SEPT9 mutant lacking the N-terminal   
region including the 0 helix (Fig. 4 A). Using the cloned frag-
ment of the SEPT2 promoter, we slightly overexpressed iso-
forms of SEPT9 (i3 and i4) and the SEPT9N mutant in HeLa 
cells (Fig. 4, B and C, input lanes; note that SEPT9N is not 
detected by the SEPT9 N-terminal antibody in Fig. 4 B [lane 4]   
but is shown at comparable levels when all are detected with 
the FLAG antibody in Fig. 4 C) or by titrating the levels of 
CMV promoter-driven plasmids (Fig. 5 A). At lower protein 
expression levels, both isoforms of SEPT9 localized to septin 
Figure  3.  SEPT9  interacts  at  the  ends  of  the  SEPT2–6–7  complex.  
(A) Small-scale tandem purification of the SEPT2–6–7 complex. Two affin-
ity purification tags, His6 and MBP, are fused to two septins, SEPT7 and 
SEPT2, respectively. Triple transfection of septin constructs in HeLa cells 
followed by His6 and then MBP purification. All constructs contain FLAG 
epitope to monitor stoichiometry of the septin complex. (lane 4) Tandem 
pull-down contains SEPT2, SEPT6, and SEPT7 in equal amounts. (lanes 
1–3)  Final  eluate  immunoblotted  with  individual  septin  antibodies  and 
the FLAG antibody (Ab). (B) Schematic representation of a heteromeric 
SEPT2–SEPT6–SEPT7 complex interacting at two interfaces. The two ends 
of the jellybean represent an NC interface with a predicted coiled coil 
projecting orthogonally to the axis of the unit complex. The G interface is 
represented by the smooth curved end of the jellybean. Only half of the 
septin unit complex is shown for simplicity. (C, lane 6) SEPT6C disrupts 
SEPT2–SEPT6–SEPT7 complex assembly. (D) Schematic representation of 
disruption in the SEPT2–SEPT6–SEPT7–SEPT9 complex upon removal of 
the SEPT6 coiled coil. (E) Small-scale tandem purification of the SEPT2–
SEPT6–SEPT7–SEPT9  complex.  Two  affinity  purification  tags,  His6  and 
MBP, are fused to two septins, SEPT7 and SEPT2, respectively. Quadruple 
transfection of septin constructs in HeLa cells followed by His6 and then 
MBP purification. All constructs contain the FLAG epitope. (lanes 6, 9, 
and 10) SEPT6C disrupts SEPT2–SEPT6–SEPT7–SEPT9 complex assembly 
(lane 6), and intermediate purification products partition the fragmented 
complex into SEPT2-SEPT6 and SEPT7-SEPT9 (lanes 9 and 10). (F) SEPT7 
W249A G mutant disrupts SEPT2–SEPT6–SEPT7–SEPT9 complex assem-
bly in vivo by preventing SEPT9 binding. Transfection of low-expressing 
GFP-FLAG-His6–wild-type (WT) and G mutant SEPT7 in HeLa cells followed 
by His6 purification and immunoblotted with FLAG, SEPT2, SEPT6, and 
SEPT9 antibodies. (G) Schematic representation of disruption in the SEPT2–
SEPT6–SEPT7–SEPT9 complex with G mutant in SEPT7. (D and G) Arrows 
demarcate the septin–septin interface that is disrupted. (H) 14 mammalian 
septins are grouped into four septin families. (I) Comparison of yeast septin 
unit complex and the mammalian SEPT2–SEPT6–SEPT7–SEPT9 complex. 
Inversion of SEPT2 and SEPT9 families from yeast to mammals. Molecular 
masses are given in kilodaltons. WB, Western blot; F, FLAG epitope; FM, 
FLAG-MBP affinity tag; FH, FLAG-His6 affinity tag.
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fibers and rings (Fig. 4, D and E) and pulled down endogenous 
SEPT2, SEPT6, SEPT7, and the longest isoform of SEPT9, 
SEPT9_i1 (Fig. 4 C, lanes 6 and 7). However, the SEPT9 mu-
tant pulled down endogenous SEPT2, SEPT6, and SEPT7, but 
no appreciable endogenous SEPT9 was isolated with the SEPT9 
mutant (Fig. 4 C, lane 8). In addition, the SEPT9 mutant local-
ized diffusely to the cytoplasm and disrupted SEPT2 fibers and 
rings (Fig. 4, D and E). Under conditions of septin overexpres-
sion, DsRed-SEPT7 formed short fibers when coexpressed with 
SEPT2 and SEPT6. Adding the two isoforms of SEPT9 drasti-
cally increased the filamentous nature of DsRed-SEPT7 fibers. 
The SEPT9 mutant was able to potently disrupt DsRed-SEPT7 
fibers when coexpressed with the other three septins (Fig. S2). 
Thus, the N terminus of SEPT9 is required for an interaction 
with itself, and the SEPT9N mutant disrupts endogenous and 
exogenous septin higher-ordered structures. Of note, the protein 
expression of the SEPT9 mutant was carefully controlled so that 
its expression level was similar to the SEPT9 isoforms. Levels 
that are too high (for example, CMV-driven septin constructs) 
cause wild-type SEPT9 isoforms to act in a dominant-negative 
manner (Fig. S4), and lower levels of the SEPT9 mutant are not 
sufficient to completely disrupt septin higher-order structures 
(not depicted).
Septin higher-order structures  
and abscission
Previously,  our  laboratory  has  demonstrated  two  major  de-
fects in cell division in HeLa cells associated with depleting 
mammalian septins: binucleation and an increase in the pres-
ence of cells connected by midbodies (Estey et al., 2010).   
Cells lacking SEPT2, SEPT7, or SEPT11 were binucleate   
after imprecise furrow ingression or contractile ring instability. 
Cells lacking SEPT9 resulted in arrest later at the abscission 
step, leaving persistent midbodies. Using the SEPT9N self- 
association mutant to block septin fibers and rings, we asked 
whether septin higher-order structures are required for cyto-
kinesis.  These  cells  were  transfected  with  either  SEPT9_i3 
or SEPT9N for 36 h, and midbodies were visualized by   
immunostaining with acetylated tubulin and counted (Fig. 5 D). 
Figure  4.  SEPT9N  caps  the  SEPT2–SEPT6–SEPT7–SEPT9  complex  and 
interferes with septin fiber and ring structures. (A) Schematic represen-
tation of SEPT9 isoforms and SEPT9N mutant. Antigenicity of SEPT9   
antibody binding to SEPT9_i3 and i4, but not the SEPT9N mutant, is 
clearly marked. (B) Low-expressing SEPT9 isoforms and the SEPT9N mu-
tant in HeLa cells. Expression of GFP-FLAG-His6-Stag-SEPT9 constructs is 
driven by the SEPT2 promoter and immunoblotted with an N-terminal SEPT9 
antibody. Quadruple tag (GFP-FLAG-His6-Stag) and intervening protease 
cleavage and MCS adds 45 kD to each fusion protein. Dominant-nega-
tive effects of slight overexpression of SEPT9N mutant on septin fibers.   
(C)  SEPT9N  mutant  prevents  SEPT9–SEPT9  interaction  in  vivo.  Trans-
fection  of  low-expressing  GFP-FLAG-His6-Stag-SEPT9_i3,  -SEPT9_i4,  and 
-SEPT9N in HeLa cells followed by His6 purification and immunoblotting 
with FLAG, SEPT2, SEPT6, SEPT7, and SEPT9_i1 antibodies. (D) Transfec-
tion of low-expressing SEPT9 isoforms and the SEPT9N mutant on septin 
fibers in HeLa cells. Transfected cells are immunostained with FLAG (red) 
and SEPT2 (green) antibodies. (E) Transfection of low-expressing SEPT9 
isoforms and SEPT9N mutant on septin rings in HeLa cells. Transfected 
cells were treated with cytochalasin D and immunostained with FLAG (red) 
and SEPT2 (green) antibodies. Boxed areas are magnified on the right. 
Molecular masses are given in kilodaltons. WB, Western blot; Exo, ex-
ogenous; Endo, endogenous; Deconv, deconvolved; N-term, N-terminal. 
Bars: (main images) 5 µm; (zoom) 1 µm.
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Figure 5.  SEPT9N and abscission defects. (A) Expression of titrated CMV promoter-driven FLAG-His6-Stag-SEPT9_i3 or -SEPT9N in wild-type HeLa cells. 
Molecular masses are given in kilodaltons. (B) Localization of SEPT2 fibers in interphase wild-type HeLa cells transfected with FLAG-His6-Stag-SEPT9_i3 or 
-SEPT9N. (C) Localization of SEPT2 in mitotic wild-type HeLa cells transfected with SEPT9N or SEPT9_i3. Late anaphase (top), early telophase (middle), 
and late telophase cells (bottom) are transfected with FLAG-SEPT9N (left) or FLAG-SEPT9_i3 (right) and immunostained with FLAG (red) or SEPT2 (green 
in top and pink in middle and bottom). Two cells in late anaphase are depicted in the first row (cell#1) and third row (cell#2). The localization of SEPT2 
as a double band is not altered in the SEPT9 mutant (thin arrowheads in magnification, second and fourth rows). Early and late telophase cells were 
cotransfected with a GFP reporter plasmid to mark the Fleming body (arrows). SEPT2 localizes predominately at the ends of the spindle midzone (thick 
arrowheads). Boxes show areas of magnification below. (D) Cotransfection of SEPT9N mutant with a GFP reporter and staining with acetylated tubulin 
(acTub; red), which reveals enrichment of midbodies. Acetylated tubulin staining is shown in the left, and the middle is the merged image with GFP to iden-
tify cotransfected cells and mark the Fleming bodies. Boxes in the merged image are magnified in the right and show midbody structures. (E) Quantitation 
of midbody enrichment of SEPT9N mutant and control (SEPT9_i3) using two different promoters. Very low expression (SEPT2 promoter) and low expres-
sion (titrated CMV promoter) of the SEPT9N mutant and control (SEPT9_i3). Under very low expression (SEPT2 promoter), there was a twofold increase 823 Mammalian septin filaments mediate abscission • Kim et al.
result in septin trimers (SEPT6–SEPT7–SEPT9) that could form 
hexamers (SEPT6–SEPT7–SEPT9–SEPT9–SEPT7–SEPT6) but 
not filaments (Fig. 5 F), although the presence of small rudi-
mentary filaments by immunocytochemistry suggests that they 
may still be capable of limited polymerization. This degree of 
septin plasticity might explain our earlier data in which SEPT2 
and SEPT9 depletion had different effects on cell division, with   
SEPT2 depletion resulting in early mitotic defects, whereas SEPT9 
depletion causes late abscission defects (Estey et al., 2010).
Another mode of septin plasticity in mammals may arise 
from the substitution of septins within the same subgroup of the 
unit complex. It has been reported by Kinoshita (2003) that 
septins within the same subgroup are able to substitute for one 
another in vitro. Furthermore, Sellin et al. (2011) have shown 
that complex septin mixtures (containing multiple septins in 
each subgroup) dissociate into protomeric octamers in vivo. 
Collectively, septins within the same subgroup are likely substi-
tuting for each other at the same position in the unit complex. 
Both modes of septin plasticity (septin subgroup substitution 
and generation of suboptimal septin–septin interactions) likely 
explain the lack of severe phenotypes seen in septin knockout 
mice, despite the fundamental role septins play in cell division.
Organizational arrangement of septins in 
the unit complex is a conserved property  
of septins
In budding yeast, four septins assemble into apolar octamers 
such that the arrangement is 11–12–3–10–10–3–12–11. In this 
order, two septins bind homotypically at the NC interface. The 
innermost septin (Cdc10) joins the tetrameric halves to form 
an octamer, and the outermost septin (Cdc11) joins with other 
Cdc11-containing octamers to form filaments. Using the posi-
tional arrangement of the septins within the octamer, McMurray 
et al. (2011) generated two different octamer mutants. The first 
mutant was a Cdc11 self-association mutant that retained septin 
octamers but prevented polymerization by inhibiting octamer join-
ing at the ends. The second mutant was a Cdc10 self-association 
mutant that generated a flipped inside-out octamer such that the 
organization was 10–3–12–11–11–12–3–10. Both were polym-
erization defective and disrupted cytokinesis in budding yeast. 
Thus, septin filaments were required for cytokinesis.
Mammalian septins fall into four subgroups, of which 
three have been shown to associate as an apolar hexamer in 
vitro (Sirajuddin et al., 2007). Native mammalian septin com-
plexes disassemble into octamers regardless of the composi-
tional number of septins, suggesting that the four subgroups 
constitute  fundamental  building  blocks  of  septin  unit  com-
plexes (Sellin et al., 2011). In addition, Sandrock et al. (2011) 
have shown that SEPT9 might also occupy a terminal position 
based  on  yeast  two-hybrid  and  yeast  three-hybrid  analyses. 
Here, we show that mammalian septin complexes can form   
octamers  that  are  arranged  as  9–7–6–2–2–6–7–9. Thus,  the 
Even when expressed at very low levels, SEPT9_i3 incorpo-
rated into septin fibers, whereas the SEPT9N partially dis-
rupted septin fibers (unpublished data). When both SEPT9_i3 
and SEPT9N were expressed at levels that were comparable 
with endogenous SEPT9 (Fig. 5 A), SEPT9N fully disrupted 
septin fibers in interphase cells (Fig. 5 B) but did not affect the 
proper localization of SEPT2 to the cleavage furrow in divid-
ing cells (Fig. 5 C). Of the 37 cells examined in late telophase, 
all showed localization of SEPT2 at the cleavage furrow (un-
published data). In control cells transfected with SEPT9_i3, 
this wild-type isoform incorporated into normal septin struc-
tures in interphase cells (Fig. 5 B) and colocalized strongly 
with SEPT2 at the cleavage furrow in dividing cells (Fig. 5 C). 
This suggests that SEPT2 does not require septin higher-order 
structures to localize to the cleavage furrow. Correct targeting 
of SEPT2 to the cleavage furrow could occur through the inter-
action with myosin II (Joo et al., 2007) or through interaction 
with complexes containing endogenous SEPT9. The late telo-
phase defects associated with SEPT9N were quantified, and 
a threefold increase in the number of cells with midbodies was 
observed when compared with wild type (Fig. 5 E). Although 
we cannot preclude the possibility that SEPT9N fails to scaf-
fold an essential protein to the midbody, our data suggest that 
septin higher-order structures may be required for later stages 
of cell division during abscission.
Discussion
Plasticity of septin complexes is a 
conserved property of septins
Yeast septin octamers are arranged 11–12–3–10–10–3–12–11. 
Although  the  order  of  the  yeast  septins  within  the  octamer 
appear  fixed,  a  recent  study  in  budding  yeast  unequivocally 
demonstrated plasticity of septin complexes (McMurray et al., 
2011). Removing the innermost septin (Cdc10) from the octa-
meric complex reconfigures the remaining septins into hexam-
ers with the following organization: 11–12–3–3–12–11. Similarly, 
removing the outermost septin (Cdc11) preserves the preexist-
ing  hexamer  template:  12–3–10–10–3–12. Although  not  op-
timal, in both cases, the remaining septins can polymerize in 
vitro and support yeast viability. However, removal of internal 
septins that connect the innermost and outermost septins, Cdc3 
or Cdc12, does not support septin filaments in vitro and does 
not support viability. This indicates that plasticity of the yeast 
septin complex and filament assembly is most tolerant to septins 
that interact homotypically. Thus, yeast septin complexes can 
adopt filamentous structures after the removal of the innermost 
and outermost septin. In mammals, septins can adopt alternate 
higher-order ring structures when only the outermost septin, 
SEPT9, is removed. Removal of the innermost septin, SEPT2, 
may prevent higher-order structures because of the inability of   
SEPT6 to interact with itself (unpublished data). This could   
in midbodies in the SEPT9 mutant compared with control (9.7 ± 1.3 vs. 4.8 ± 0.6). Under low expression (titrated CMV promoter), there was a 2.8-fold 
increase in midbodies in SEPT9 mutant compared with control (20.7 ± 0.9 vs. 7.3 ± 0.7). Error bars show SEM. (F) Model of mammalian septin complex 
assembly. WB, Western blot. Bars: (B, C [main images], and D) 5 µm; (C, zoom) 1 µm.
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cytokinetic events. A better approach might be to specifically 
mutate the 0 helix in an otherwise intact SEPT N terminus 
(thereby retaining the lipid-binding and protein interaction 
domains). Alternatively, generating flipped inside-out octam-
ers using SEPT2 self-association mutants would further add 
to the evidence that mammalian septin filaments are required 
for cytokinesis.
Requirement of septin filaments in 
cytokinesis is a conserved property  
of septins
Septins have two well-established roles as scaffolds and diffu-
sion barriers at the mother–bud neck in yeast. Intuitively, 
scaffold functions may exist for small assemblies of septin 
complexes, whereas diffusion barriers may require long, con-
tinuous filaments to block membrane protein movement. Yeast 
septins undergo dramatic changes at the mother–bud neck. 
FRAP experiments on GFP-septins have demonstrated oscillat-
ing dynamic and static properties of the septins through cell 
division that correlate with posttranslational modification of 
septins (Dobbelaere et al., 2003). Moreover, a 90° rotation in 
septin structures at the mother–bud neck was detected with 
fluorescence anisotropy using fixed GFP moieties to yeast septins 
(Vrabioiu and Mitchison, 2006). Collectively, these results sug-
gest major structural changes in septins that could increase or 
decrease the relative contribution of septins as either scaffolds 
or diffusion barriers. Our data suggest that, at least in some cir-
cumstances, SEPT9 would be present at the terminal position of 
septin complexes and might therefore be responsible for subunit 
polymerization. We have previously shown that depletion of 
SEPT9 resulted in defects only at the late stages of cell division 
but did not affect the early septin role in contractile ring stabil-
ity. Similarly, in this study, we observed a similar result using 
mutants of SEPT9 that prevent polymerization. This indicates 
that subunits that are inefficient at polymerization are still capa-
ble of functioning during early stages of cytokinesis (in which 
they  may  play  a  scaffolding  role)  but  that  filament-forming 
septins are required for late stages of cytokinesis (consistent 
with a diffusion barrier role). In support of a scaffolding role 
during early stages in cell division, septins have been observed 
at the metaphase plate and act as a scaffold for mitotic motors 
and checkpoint proteins to coordinate chromosome congression 
and separation (Spiliotis et al., 2005). During early anaphase, 
septins have been shown to act as a scaffold to recruit citron and 
Rho kinases, and this has been shown to promote efficient phos-
phorylation of myosin light chain necessary to stabilize the con-
tractile ring (Joo et al., 2007). The notion that SEPT9 may be 
important for a diffusion barrier–type role at later steps in mito-
sis is consistent with our previous observation that depletion of 
SEPT9 resulted in loss of the exocyst complex from the mid-
body (Estey et al., 2010), which is very similar to the diffusion-
limited domain between the split septin rings that localizes the 
exocyst at the mother–bud neck in yeast (Dobbelaere and Barral, 
2004). In summary, the organizational principles that govern 
septin complex assembly are conserved from yeast to mam-
mals, and as in yeast, septin filaments are required for the final 
steps of cytokinesis.
in vitro 7–6–2–2–6–7 hexamer is an incomplete mammalian 
septin complex, and a septin member of the fourth subgroup 
satisfies septin octamer assembly, such that the organizational 
principles of mammalian septin complex assembly are similar 
to budding yeast. In this arrangement, two septins homotypi-
cally interact at NC interfaces: two SEPT2 proteins join the 
two tetrameric arms of the complex, and two SEPT9 proteins 
interact to join octamers into larger structures. The N and C   
termini of SEPT9 undergo extensive alternative splicing, so it will 
be of great interest to determine whether the different splice 
forms alter interaction properties. Interestingly, it was reported 
by Chacko et al. (2005) that when stably overexpressed in cell 
lines, one of the small isoforms of SEPT9 (SEPT9_i4) was 
able to disrupt endogenous septin fibers. It was also found that 
SEPT9_i3, but not SEPT9_i4, could rescue cytokinesis defects 
caused by depletion of all SEPT9 isoforms (Estey et al., 2010). 
This  raised  the  possibility  that  smaller  isoforms  of  SEPT9 
(SEPT9_i4–5) might act as chain terminators. Consistent with 
this idea, the SEPT9N mutant used in this study is shorter 
than the smallest isoform of SEPT9, SEPT9_i5, and disrupts 
endogenous septin fibers and rings. However, in contrast to the   
previous studies, we found that SETP9_i4 was able to in-
corporate into septin filaments and rings and associated with   
endogenous  septins,  inconsistent  with  a  potent  capacity  for 
chain termination. It is possible that SEPT9_i4 is weaker in its 
capacity for chain termination than the shorter forms of SEPT9 
and that only in the cases of high expression (Chacko et al., 
2005) or when present as the only form of SEPT9 (Estey et al., 
2010) can inhibition of septin polymerization be seen, whereas 
only low levels of SEPT9N (or possibly SEPT9_i5) are suf-
ficient to achieve chain disruption.
Our analyses have taken advantage of the same types of 
self-association mutants in yeast that generated octamers, and 
we show that an N-terminal deletion truncation in SEPT9 is   
a  self-association  mutant  that  disrupts  septin  higher-order 
structures and is required for the late stages of cytokinesis. It 
seems unexpected that the SEPT9N mutant does not interact 
with endogenous SEPT9, even though it appears as though it 
is expressed at levels similar to endogenous SEPT9 (Fig. 4 B 
and Fig. 5 A). At levels expected to be at or near endogenous 
levels, endogenous SEPT9 would be expected to occupy the 
other tetrameric arm of the unit complex, and a reduction (not 
a complete absence) of binding to endogenous SEPT9 would 
be expected. However, because transfection of HeLa cells in 
our hands is between 50 and 60%, the levels of exogenously 
expressed septins in the transfected cells is underestimated. 
The SEPT9N mutant is likely in excess of the level of en-
dogenous SEPT9, thereby capping the octamer at both ends. 
This mutant also contains a large N-terminal deletion that in 
addition to disrupting septin higher-order structures, could 
interfere with other processes. For instance, septin-associated 
Rho guanine nucleotide exchange factor is an exchange factor 
for RhoA and has been found to bind to the N terminus of 
SEPT9 (Nagata and Inagaki, 2005), and deletion up to the 0 
helix also removes a putative phospholipid binding site. Thus, 
we cannot rule out the possibility that lipids or proteins that 
bind to the N terminus of SEPT9 might be involved in late   825 Mammalian septin filaments mediate abscission • Kim et al.
of Michigan, Ann Arbor, MI). HRP secondary antibodies were used 
at 1:5,000 (Jackson ImmunoResearch Laboratories, Inc.). Rhodamine- 
phalloidin was used at 1:500.
Immunofluorescence
Cells were washed with room temperature PBS and then fixed in 1% PFA 
in PBS for 20 min at room temperature. PFA was inactivated, and cells 
were permeabilized using buffer D (PBS with 25 mM glycine, 25 mM am-
monium chloride, and 0.1% Triton X-100) for 20 min. Cells were blocked 
in PBS with 5% horse serum for 1 h. Standard immunofluorescence proce-
dures were used with 1-h incubations of primary and secondary anti-
bodies. Dilutions of antibodies used for immunofluorescence were mouse 
anti-FLAG at 1:1,000 (M2), mouse anti-SEPT9 undiluted (10C10; Estey et al., 
2010), rabbit anti-SEPT2 at 1:100 (Xie et al., 1999), and rabbit anti-
SEPT7 at 1:10. Fluorescent secondary antibodies conjugated to Cy3 and 
Cy5  were  used  at  1:500  (Jackson  Immunologicals).  Coverslips  were 
mounted using fluorescence mounting medium (Dako). Fixed cells were 
imaged at room temperature using an inverted fluorescence microscope 
(DMIRE2; Leica) equipped with an IEEE 1394–based digital camera 
(ORCA-ERG  model  C4742-95-12ERG;  Hamamatsu  Photonics).  Images 
were acquired using a 100× oil immersion objective (HCX Plan Apochro-
mat  with  numerical  aperture  of  1.40–0.7;  Leica).  The  equipment  was 
driven by Volocity acquisition software (PerkinElmer) and powered by a 
Power Mac G5 (Apple). Deconvolved images were processed using the 
Fast Restorative function in Volocity. This is a quick method that provides 
images with high contrast by using a single-pass, nearest neighbor subtrac-
tive method. Deconvolution using this method relies on a point spread func-
tion to determine what light is out of focus and removes that light from the 
image. A point spread function for a wide-field microscope was created for 
each channel using the following settings: numerical aperture = 1.4, me-
dium refractive index = 1.518, and emission wavelength of 600 nm (Cy3) 
and 515 nm (GFP).
Online supplemental material
Fig. S1 shows the raw data for the quantitation performed in Fig. 2 D. 
Fig. S2 depicts the filamentous nature of septins when SEPT9 isoforms are 
cotransfected with SEPT2, SEPT6, and SEPT7. Fig. S3 shows the absence 
of endogenous septins that copurify with tandem affinity–purified, over-
expressed septin complexes. Fig. S4 contains low and high expression of dif-
ferent isoforms of SEPT9 and its effect on endogenous SEPT2 higher-order 
structures. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201106131/DC1.
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Materials and methods
Cell culture, transfection, and drug treatments
HeLa cells stably expressing the tetracycline-controlled transactivator pro-
tein (Tet-ONs) and wild-type HeLa cells (American Type Culture Collec-
tion) were cultured in DME with 10% FBS and grown at 37°C with 5% 
CO2. Cells were transfected with either Lipofectamine 2000 (Invitrogen) 
or jetPRIME (VWR) using the manufacturer’s recommendations. HeLa Tet-
ONs were treated for 50 min with 3 µM cytochalasin D (Sigma-Aldrich) to 
disrupt actin and induce septin ring assembly. Septin fibers were disrupted 
using the SEPT9 mutant in both HeLa Tet-ONs and wild-type HeLa cells. 
Any wild-type HeLa cells connected via a microtubule bridge, as judged by 
acetylated tubulin staining (T7451; Sigma-Aldrich), were counted as being 
connected by a midbody (Estey et al., 2010).
Plasmid construction
FLAG constructs. A FLAG vector was generated by oligonucleotide cloning 
the FLAG epitope into pcDNA3.0(+). This FLAG vector was subsequently 
modified so that the multiple cloning site (MCS) was altered to include 
EcoRI and XhoI sites that are downstream and in frame with the FLAG epi-
tope. Additional purification and epitope tags were added between the 
FLAG epitope and the MCS, resulting in a FLAG-MBP vector and a FLAG-
His6-Stag (polyhistidine and S-tag) vector. These vectors were generated by 
PCR cloning and were used to purify septin complexes on Ni-NTA agarose 
and amylose-agarose columns. Human septin genes containing any inter-
nal EcoRI or XhoI restriction sites were mutated. Septins were PCR cloned 
or subcloned into respective FLAG, FLAG-His6, or FLAG-MBP vectors with 
EcoRI and XhoI.
Fluorescent constructs. The MCS of pEGFP-C1 (Takara Bio Inc.) was 
altered to include EcoRI and XhoI sites that are downstream and in frame 
with the enhanced GFP protein. For lower expression of the septin genes, 
we removed the strong CMV promoter and replaced it with the SEPT2 pro-
moter. To this end, the CMV promoter was cut out with AseI and AgeI, and 
the SEPT2 promoter was PCR cloned in its place. A >25-kb bacmid contain-
ing the full SEPT2 gene was obtained, and a 400-bp region upstream of the 
transcriptional start site of SEPT2 was generated using PCR. Additional pu-
rification and epitope tags were added between the enhanced GFP protein 
and the MCS, ultimately resulting in a GFP-FLAG-His6-Stag vector driven 
under the SEPT2 promoter. SEPT7-DsRed was generated by PCR cloning 
SEPT7 into pDSRed1-C1 (Takara Bio Inc.) using XhoI and EcoRI.
Septin mutants. All septin mutant genes were PCR cloned or sub-
cloned using EcoRI and XhoI. Human SEPT6 C-terminal truncation (amino 
acids 1–333) was generated using PCR. Human SEPT9 N-terminal trunca-
tion including the 0 helix (amino acids 268–568) was generated using 
PCR. SEPT7 G mutant (W249A) was generated by PCR mutagenesis in 
pBluescript SK() and subcloned into respective vectors.
Septin complex isolation (tandem affinity purification)
Septin constructs were transfected into HeLa Tet-ONs grown on 6-well tissue-
culture plates and harvested 18–24 h later. Cells were washed with cold 
PBS and lysed using buffer A (PBS, 20 mM imidazole, 1% Triton X-100, 
and a protease tablet). Lysates were clarified for 40 min at 200,000 g. The 
clarified supernatant was incubated with Ni-NTA agarose (QIAGEN) for   
1 h, washed three times in buffer B (PBS, 20 mM imidazole, and 0.1% 
Triton X-100), and eluted in buffer C (PBS, 150 mM imidazole, and 0.1% 
Triton X-100). The eluate was incubated with amylose-agarose (New Eng-
land Biolabs, Inc.) for 1 h and washed three times in buffer B. SDS-PAGE 
loading buffer was added to beads and run on 10% SDS-PAGE gels.
Septin complex isolation (single purification)
Septin constructs driven under the SEPT2 promoter were transfected into 
HeLa Tet-ONs grown on 6-well plates and harvested 18–24 h later. Cells 
were lysed and washed as in the previous paragraph. SDS-PAGE loading 
buffer was added to beads, run on 10% SDS-PAGE gels, and probed with 
septin antibodies.
Immunoblotting
Standard immunoblotting procedure was performed using 1-h incuba-
tions of primary and secondary antibodies. Dilutions of antibodies used 
for immunoblotting were as follows: mouse anti-FLAG at 1:7,500 (M2; 
Sigma-Aldrich),  mouse  anti–glyceraldehyde  3-phosphate  dehydroge-
nase at 1:50,000, rabbit anti-SEPT9 at 1:1,000 (Surka et al., 2002), 
rabbit  anti-SEPT2  at  1:500  (Xie  et  al.,  1999),  rabbit  anti-SEPT6  at 
1:100 (N1), rabbit anti-SEPT7 at 1:1,000 (Santa Cruz Biotechnology, 
Inc.), and rabbit anti-SEPT9_i1 at 1:5,000 (gift from E. Petty, University   JCB • VOLUME 195 • NUMBER 5 • 2011   826
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